PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Strategy to boost prostate cancer treatment efficacy devised at Rutgers Health

2024-01-22
(Press-News.org) Rutgers researchers can predict which patients will benefit from a popular prostate cancer drug – and have devised a strategy that may make the treatment work longer.

“This work should help doctors know which patients’ prostate cancers will and won’t respond to the androgen deprivation therapy enzalutamide, which can slow prostate cancer growth by disrupting androgen receptor signaling,” said Antonina Mitrofanova, associate professor of Biomedical and Health Informatics, associate dean for research at the Rutgers School of Health Professions, researcher at Rutgers Cancer Institute of New Jersey, and lead author of the study. “We hope this gets effective treatment to more patients in less time, and we hope follow-up research makes the benefit that many patients receive from enzalutamide work longer.”

For the study in Nature Communications, Mitrofanova’s team developed computational algorithms to discover why the prostate cancer drug enzalutamide (sold under the brand name Xtandi) never works for some patients and why it eventually stops working in others.

The researchers analyzed advanced prostate cancer patient data to map interactions among molecular pathways and their upstream transcription factors (proteins that regulate the expression of multiple genes) in prostate cancer cells. Their attention centered on the MYC pathway because of its known role in prostate cancer. They discovered that another protein and transcription factor, NME2, works closely with MYC in advanced prostate cancer cells that resist enzalutamide and continue to spread.

Analysis of medical records found that patients with elevated levels of MYC and NME2 were five times less likely than others to benefit from enzalutamide. The analysis also found that protein levels climbed significantly in most patients who only responded to the drug temporarily.

The Rutgers team worked with colleagues at Northwestern University, Sarki Abdulkadir and Vishal Kothari, to confirm these findings with experiments on cancerous tissues and laboratory mice. Their work again showed that elevated levels of MYC and NME2 were associated with poor response to enzalutamide, both in tissue samples and live mice.

This research also demonstrated that MYC and NME2 could rise in response to enzalutamide usage – which explains why the drug could eventually stop working. But there was a silver lining: Reducing NME2 and, thus, MYC levels restored the efficacy of enzalutamide in cancers that had grown resistant to its effects.

Any improvement in prostate cancer treatment would produce widespread benefits, the researchers said. Prostate cancer is the second most common cancer in the United States and the fourth most common cancer worldwide.

This study marks a significant step toward understanding and treating advanced prostate cancer, in which the cancer has spread beyond the prostate itself and becomes resistant to the older androgen deprivation therapies that are typically used as initial treatments for the disease.

The results from the study indicate patients with elevated levels of MYC and NME2 who become resistant to enzalutamide may still respond to alternative medications, such as abiraterone (ZYTIGA), which don’t stop working when MYC and NME2 levels rise and could significantly benefit from therapeutic targeting of MYC axes, restoring efficacy of enzalutamide and making it work longer for these patients.

“The results from both the computational analysis and the lab experiments were robust,” said Mitrofanova. “But we hope to follow this work with a trial in human patients. That’s the next step.”

END


ELSE PRESS RELEASES FROM THIS DATE:

Salad in space? New study says it's not a healthy choice

Salad in space? New study says its not a healthy choice
2024-01-22
Lettuce and other leafy green vegetables are part of a healthy, balanced diet — even for astronauts on a mission. It’s been more than three years since the National Aeronautics and Space Administration made space-grown lettuce an item on the menu for astronauts aboard the International Space Station. Alongside their space diet staples of flour tortillas and powdered coffee, astronauts can munch on a salad, grown from control chambers aboard the ISS that account for the ideal temperature, amount of water and light ...

Sexual minority young people in Canada more likely to experience harmful police contact

2024-01-22
Toronto, ON – While there has been much public scrutiny and research on police interactions and violence towards sexual minorities in the United States, there is a gap in the current literature on how sexual minorities fare with law enforcement contact in Canada. A new study published in the Annals of Epidemiology aims to fill this research gap by examining the relationship between sexual orientation and experiences with police contact, including intrusion and harassment from the police, in Canada. Among a sample of 940 adolescents and young adults across Canada, the study found that the prevalence of police contact was highest among persons ...

University Hospitals OBGYN and urologist Joseph Welles Henderson, MD, named InterStim™ Center of Excellence

University Hospitals OBGYN and urologist Joseph Welles Henderson, MD, named InterStim™ Center of Excellence
2024-01-22
CLEVELAND -- Joseph Welles Henderson, MD, of University Hospitals has been named an InterStim™ Center of Excellence by Medtronic (NYSE: MDT), the world’s largest medical device manufacturer. The designation is awarded to caregivers who have demonstrated particular expertise in the use of the InterStim™ system to treat overactive bladder, as well as non-obstructive urinary retention and chronic fecal incontinence. Dr. Henderson is an OBGYN and urologist, and specializes in female pelvic medicine and reconstruction ...

Thinning of brain region may signal dementia risk 5-10 years before symptoms

2024-01-22
SAN ANTONIO, Jan. 22, 2024 — A ribbon of brain tissue called cortical gray matter grows thinner in people who go on to develop dementia, and this appears to be an accurate biomarker of the disease five to 10 years before symptoms appear, researchers from The University of Texas Health Science Center at San Antonio (also called UT Health San Antonio) reported. The researchers, working with colleagues from The University of California, Davis, and Boston University, conducted an MRI brain imaging study published ...

Zeng researching techniques for achieving supply chain security for the Internet of Things

2024-01-22
Qiang Zeng, Associate Professor, Computer Science, received funding for the project:  "Towards Lifetime Supply Chain Security for Internet of Things: Testing an Update Before Trusting It." The global Internet of Things (IoT) market size is expected to rise substantially by 2029. IoT devices are manufactured by various companies around the world, and thus, should not be trusted by default. Zeng aims to ensure lifetime supply chain security of IoT devices. To attain this objective, he is proposing to test an IoT device and every firmware update through ...

Arafin conducting research aimed at securing chiplet-based semiconductor manufacturing from untrusted supply chains

2024-01-22
Md Tanvir Arafin, Assistant Professor, Cybersecurity Engineering, received funding for the project: "Securing Chiplet-based Semiconductor Manufacturing from Untrusted Supply Chains." Monolithic integrated circuit (IC) design is reaching the physical limit to accommodate the ever-increasing demand of cramming more transistors in a chip. To address this, novel design primitives that move from monolithic design practices to heterogeneous integration of IC primitives in a 2.5 or 3D structure have emerged. ...

Good and bad news for people with low back pain

Good and bad news for people with low back pain
2024-01-22
Low back pain is a major cause of disability around the globe, with more than 570 million people affected. In the United States alone, health care spending on low back pain was $134.5 billion between 1996 and 2016, and costs are increasing.   "The good news is that most episodes of back pain recover, and this is the case even if you have already had back pain for a couple of months," University of South Australia Professor Lorimer Moseley says.   "The bad news is that once you have had back pain for more than a few months, the chance ...

GIST researchers investigate strange transient responses of organic electrochemical transistors

GIST researchers investigate strange transient responses of organic electrochemical transistors
2024-01-22
Organic mixed ionic–electronic conductors (OMIECs) are a highly sought-after class of materials for non-conventional applications, such as bioelectronics, neuromorphic computing, and bio-fuel cells, owing to their two-in-one electronic and ionic conduction properties. To ensure a much wider acceptance of these fascinating materials, there is a need to diversify their properties and develop techniques that allow application-specific tailoring of the features of OMIEC-based devices. A crucial aspect of this process is to develop strategies for evaluating the various properties of these ...

Protein discovery could help solve prostate cancer drug resistance

2024-01-22
SPOKANE, Wash. – Researchers have identified a receptor protein known as CHRM1 as a key player in prostate cancer cells’ resistance to docetaxel, a commonly used chemotherapy drug to treat advanced cancer that has spread beyond the prostate. The discovery opens the door to new treatment strategies that could overcome this resistance. This could ultimately help extend the lives of those with prostate cancer, one of the leading causes of cancer deaths among men.   Led by a team of scientists at Washington State University, ...

Improvement of social isolation and loneliness and excess mortality risk in people with obesity

2024-01-22
About The Study: The findings of this study of 398,000 UK Biobank participants support the improvement of social isolation and loneliness in people with obesity to decrease obesity-related excess risk of mortality. Authors: Lu Qi, M.D., Ph.D., of the Tulane University School of Public Health and Tropical Medicine in New Orleans, is the corresponding author.  To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/  (doi:10.1001/jamanetworkopen.2023.52824) Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, ...

LAST 30 PRESS RELEASES:

Fig trees convert atmospheric CO2 to stone

Intra-arterial tenecteplase for acute stroke after successful endovascular therapy

Study reveals beneficial microbes that can sustain yields in unfertilized fields

Robotic probe quickly measures key properties of new materials

Climate change cuts milk production, even when farmers cool their cows

Frozen, but not sealed: Arctic Ocean remained open to life during ice ages

Some like it cold: Cryorhodopsins

Demystifying gut bacteria with AI

Human wellbeing on a finite planet towards 2100: new study shows humanity at a crossroads

Unlocking the hidden biodiversity of Europe’s villages

Planned hydrogen refuelling stations may lead to millions of euros in yearly losses

Planned C-sections increase the risk of certain childhood cancers

Adults who have survived childhood cancer are at increased risk of severe COVID-19

Drones reveal extreme coral mortality after bleaching

New genetic finding uncovers hidden cause of arsenic resistance in acute promyelocytic leukemia

Native habitats hold the key to the much-loved smashed avocado’s future

Using lightning to make ammonia out of thin air

Machine learning potential-driven insights into pH-dependent CO₂ reduction

Physician associates provide safe care for diagnosed patients when directly supervised by a doctor

How game-play with robots can bring out their human side

Asthma: patient expectations influence the course of the disease

UNM physician tests drug that causes nerve tissue to emit light, enabling faster, safer surgery

New study identifies EMP1 as a key driver of pancreatic cancer progression and poor prognosis

XPR1 identified as a key regulator of ovarian cancer growth through autophagy and immune evasion

Flexible, eco-friendly electronic plastic for wearable tech, sensors

Can the Large Hadron Collider snap string theory?

Stuckeman professor’s new book explores ‘socially sustainable’ architecture

Synthetic DNA nanoparticles for gene therapy

New model to find treatments for an aggressive blood cancer

Special issue of Journal of Intensive Medicine analyzes non-invasive respiratory support

[Press-News.org] Strategy to boost prostate cancer treatment efficacy devised at Rutgers Health